Aberrant WNT signaling is a key oncogenic driver in colon cancer, mostly as a consequence of mutations in Adenomatous Polyposis Coli (APC), β-catenin or axin [56]. This evidence concerns the gene AXIN1 and malignant colon neoplasm.